Effect With Baseline HAQ | Odds Ratio | 95% CI | p-Value | |
---|---|---|---|---|
Age | 1.073 | 1.015 | 1.133 | 0.0130 |
Female | 2.591 | 0.350 | 19.231 | 0.3517 |
Corticosteroid use | 3.094 | 0.677 | 14.144 | 0.1452 |
Other DMARD use | 0.124 | 0.020 | 0.776 | 0.0258 |
Tramadol/Opioid use | 3.997 | 0.916 | 17.437 | 0.0652 |
Antidepressant use | 3.446 | 0.779 | 15.250 | 0.1031 |
Patient Global VAS at first visit | 1.024 | 0.993 | 1.057 | 0.1321 |
HAQ at first visit | 5.645 | 1.534 | 20.775 | 0.0092 |
Effect Without Baseline HAQ | Odds Ratio | 95% CI | p-Value | |
Age | 1.075 | 1.023 | 1.130 | 0.0042 |
Female | 6.494 | 1.04 | 40.0 | 0.0456 |
Corticosteroid use | 5.099 | 1.290 | 20.159 | 0.0202 |
Other DMARD use | 0.137 | 0.028 | 0.674 | 0.0145 |
Tramadol/Opioid use | 3.272 | 0.901 | 11.888 | 0.0717 |
Antidepressant use | 5.255 | 1.324 | 20.852 | 0.0183 |
Patient Global VAS at first visit | 1.041 | 1.012 | 1.071 | 0.0055 |